Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ZBH
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Zimmer Biomet Holdings Inc (ZBH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Zimmer Biomet (ZBH) trades at $96.00, up 1.07% today, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 69.87% gross margin and trades at a P/E of 23.06. Recent leadership promotions and dividend declarations highlight ongoing corporate activity. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated from prior peaks.
The outlook is positive with analyst consensus pointing to a $103.11 price target, though risks include rising debt levels and competitive pressures. Earnings momentum and institutional accumulation support upside, but investors should weigh margin trends against valuation.
Read full analysis

Key Stats

  • Market Cap
    $18.12B
  • Volume
    1,150,504
  • Sector
    Health
  • 52W High
    $103.98
  • 52W Low
    $79.58
  • Typical Hold Time
    89 Days
  • Enterprise Value
    $25.19B
  • Div Yield
    1.01%
  • Trading Activity
    100% Sell | 0% Buy
$93.6
52W Low: $79.58
11 May 2026
52W High: $103.98
22 Oct 2025

Track Zimmer Biomet Holdings Inc (ZBH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Zimmer Biomet Holdings Inc has traded between a low of $79.58 and a high of $103.98, highlighting its annual price range. Buy and sell Zimmer Biomet Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Most Recent News

Content is generated by Aura AI

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...

Market News
19 minutes ago
Iba (Ion Beam Applications S.A.)
Bullish
news icon
First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...

Market News
19 minutes ago
Wiseqey Corp.
Bullish
news icon
WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...

Market News
19 minutes ago
Iba (Ion Beam Applications S.A.)
Bullish
news icon
IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $18.12B
  • Volume
    1,150,504
  • Sector
    Health
  • 52W High
    $103.98
  • 52W Low
    $79.58
  • Typical Hold Time
    89 Days
  • Enterprise Value
    $25.19B
  • Div Yield
    1.01%
  • Trading Activity
    100% Sell | 0% Buy
$93.6
52W Low: $79.58
11 May 2026
52W High: $103.98
22 Oct 2025

Track Zimmer Biomet Holdings Inc (ZBH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Zimmer Biomet Holdings Inc has traded between a low of $79.58 and a high of $103.98, highlighting its annual price range. Buy and sell Zimmer Biomet Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!